Rakuten Medical Stock

rakuten-med.comBioTechFounded: 2013Funding to Date: $655.92MM

Rakuten Medical is a biotechnology company focused on developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in pre-clinical studies have shown to lead to rapid and selective cell killing and tumor necrosis.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Rakuten Medical, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Takashi Toraishi Ph.D
President & Chief Operating Officer
Carlos Garcia
Chief Technology Officer
Miguel Garcia-Guzman Ph.D
Vice Chairman & CSO
Agatha Martindale
Vice President, Finance
Merrill Biel Ph.D
Chief Medical Officer
Hiroshi Mikitani
Chief Executive Officer & Chairman

Board Members

Hiroshi Mikitani
Hiroshi Mouri
Miguel Garcia-Guzman Ph.D

Other companies like Rakuten Medical in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

Rakuten Medical, a San Mateo CA-based biotechnology company focused on developing and commercializing innovative oncology products for multiple indications, raised $166M in Series D funding